Advertisement
News
Subscribe to MDT Magazine News

Some women worry too much about breast cancer returning, U-M study finds

March 28, 2011 11:38 am | by EurekAlert | Comments

(University of Michigan Health System) Most women face only a small risk of breast cancer coming back after they complete their treatment. Yet a new study from the University of Michigan Comprehensive Cancer Center finds that nearly half of Latinas who speak little English...

TOPICS:

Garage sale at Scrushy's former estate nets $160K

March 28, 2011 10:45 am | by The Associated Press | Comments

Buyers walked away with more than $160,000 worth of items at a two-day garage sale at the Alabama estate once owned by HealthSouth Corp. founder Richard Scrushy.Consultant John Jones says about $120,000 worth of Scrushy's former belongings were sold Saturday in Vestavia Hills. More than $40,000...

Syneron Medical Announces Availability of Its Annual Report on Form 20-F Through Its Website

March 28, 2011 10:45 am | by The Associated Press | Comments

Syneron Medical Ltd. (NASDAQ: ELOS), http://www.syneron.com (http://www.syneron.com/) , the leading global aesthetic device company, today announced that its annual report on Form 20-F, containing audited consolidated financial statements for the year ended December 31, 2010, as filed...

Advertisement

Cynosure to Present at 10th Annual Needham Healthcare Conference

March 28, 2011 10:37 am | by Bio-Medicine.Org | Comments

WESTFORD, Mass., March 28, 2011 /- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the 10th Annual Needham Healthcare Conference in New York City. The presentation by...

TOPICS:

New Harvard-MIT device to detect single cancer cells

March 28, 2011 10:36 am | by Mass High Tech: The Journal of New England Technology | Comments

A new microfluidic device that can detect single cancer cells in blood, potentially telling doctors if cancer has spread, has been developed jointly by professors at Harvard Medical School and MIT.

TOPICS:

Detroit Medical Center Becomes First in Southeast Michigan to Study an Implantable Device, Designed to Reduce Patient Time to the ER and Improve Survival Rates From Heart Atta...

March 28, 2011 10:36 am | by Bio-Medicine.Org | Comments

DETROIT, March 28, 2011 /PRNewswire-USNewswire/ -- Detroit Medical Center (DMC) Cardiovascular Institute (CVI) announced its first implant of the AngelMed Guardian cardiac monitor and alert system. The system is designed to reduce the time it takes patients to get to the emergency room...

TOPICS:

FDA Warns Consumers to Stop Using Soladek Vitamin Solution

March 28, 2011 10:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 28, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning consumers to stop using Soladek, a vitamin-solution product marketed by Indo Pharma, S.A., of the Dominican Republic, because the product may contain dangerously high levels of...

TOPICS:

Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American Colle...

March 28, 2011 10:35 am | by Bio-Medicine.Org | Comments

BASKING RIDGE, N.J., March 28, 2011 /- Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of...

TOPICS:
Advertisement

AmeriCares and AstraZeneca Work Together Delivering Critical Medicines to Help People Living with Chronic Diseases in the U.S.

March 28, 2011 10:35 am | by Bio-Medicine.Org | Comments

STAMFORD, Conn., March 28, 2011 /PRNewswire-USNewswire/ -- AmeriCares and AstraZeneca have teamed to deliver critical medicines to help people living with chronic diseases throughout the United States. AstraZeneca has donated $5 million in cardiovascular and gastrointestinal medications...

TOPICS:

Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference

March 28, 2011 10:35 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., March 28, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 10th Annual Needham Healthcare Conference in New York City on Tuesday, April 5, 2011 at 10:00 a.m....

TOPICS:

Radiology Reports in the Age of Smartphones, Part 1 in a Series

March 28, 2011 10:33 am | by Diagnostic Imaging | Comments

In the near future, expect to see the development of m-health reporting apps that will handle the issues of security, privacy, and documentation of the receipt of the information. It is expected that many m-health apps will be used for tracking chronic conditions and for identification...

TOPICS:

Amid Japan crisis, hunt for better radiation care

March 28, 2011 9:45 am | by LAURAN NEERGAARD - AP Medical Writer - Associated Press | Comments

Japan's nuclear emergency highlights a big medical gap: Few treatments exist to help people exposed to large amounts of radiation.But some possibilities are in the pipeline — development of drugs to treat radiation poisoning, and the first rapid tests to tell who in a panicked crowd would...

RNA-Exporting Machine Deciphered at Berkeley Lab's Advanced Light Source

March 28, 2011 9:35 am | by Lawrence Berkeley National Laboratory | Comments

A tiny motor tasked with one of nature's biggest jobs is now better understood. The molecular machinery that helps export messenger RNA from a cell's nucleus has been structurally mapped at Berkeley Lab's Advanced Light Source. Messenger RNA conveys genetic information from the nucleus to...

TOPICS:

Quest starts tender offer for Celera

March 28, 2011 8:45 am | by The Associated Press | Comments

Quest Diagnostics has opened its tender offer in an attempt to buy Celera Corp. for $671 million, the company said Monday.The medical laboratory operator said earlier this month it would pay $8 cash for each share of Calera, a premium of 28 percent at the time. The deal price includes Celera's...

Reduced Hours for Trainees Has Had Little Effect in U.S.

March 28, 2011 8:32 am | by Diagnostic Imaging | Comments

HealthDay News - Shorter work week for doctors in training has had little impact, positive or negative, on patient safety

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading